When dye-labeled PLGA-PEG-LHRH NCs were compared to other treatment groups, a sharper and greater fluorescence intensity signal at the tumor location indicated a comparatively higher tumor localization 24 h later. The gene discussed is GNRH1; the disease is neoplasm.